Clinical Trial Update: Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma [NA]

View source ↗

Summary

Clinical trial update on the Optune NovoTTF-100A device for recurrent atypical and anaplastic meningioma; the pilot study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Meningioma
• Atypical Meningioma
• Meningioma

Drugs mentioned

• OPTUNE

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Brain Cancer | NA | Status: ACTIVE_NOT_RECRUITING